BIOQuébec is pleased with INESSS' conclusion and recommendation regarding the genetic screening test for complications related to the 5-FU chemotherapy treatment

The Institut national d’excellence en santé et services sociaux (INESSS) recommended to use an affordable genetic screening test to avoid cases where patients experience complications following the Xeloda chemotherapy treatment, commonly known as 5-FU in its intravenously administered form.

NewsCatherine LamontagneMarch 22, 2017bioquébec, chemotherapy, treatment, 5-FU, INESS, genetic tests